Scarica l'app Stockscreener
41.80
0.32%
0.16
Atricure Inc Borsa (ATRC) Ultime notizie
Inspire Medical Systems appoints Michael H. Carrel to its board - Medical Buyer
AtriCure, Inc. (ATRC) Beat Earnings Estimates. Here’s What Could Drive ATRC Stock Next - Yahoo Finance
AtriCure, Inc. (ATRC) Q2 2026 10-Q Report: Financial Performance, Earnings, and Stockholder Updates - Minichart
AtriCure CEO Carrel joins Inspire Medical board of directors - MassDevice
AtriCure, Inc. 2026: Revenue $153.6M, EPS $0.18— 10-Q Summary - TradingView
[10-Q] AtriCure, Inc. Quarterly Earnings Report - Stock Titan
Inspire Medical Systems adds AtriCure CEO to board - Investing.com
Inspire Medical Systems adds AtriCure CEO to board By Investing.com - Investing.com South Africa
AtriCure’s Profitability Inflection and 2026 Guidance Could Be A Game Changer For AtriCure (ATRC) - simplywall.st
Inspire's New Director Comes From AtriCure, Which Helped Over 1M Patients - Stock Titan
AtriCure Inc (ATRC) Institutional Confidence - TradingKey
AtriCure Inc (ATRC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ATRC|AtriCure Inc|Price:35.040|Chg%:+2.040 - TradingKey
AtriCure Inc (ATRC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AtriCure Inc (ATRC) Balance Sheet - TradingKey
AtriCure Inc (ATRC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AtriCure Inc (ATRC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Atricure (ATRC) - The Globe and Mail
Atricure (ATRC) Receives a Buy from Stifel Nicolaus - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Prime Medicine, Inc. (PRME) and Community Health (CYH) - The Globe and Mail
BTIG Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $45 - Moomoo
AtriCure Reports Second Quarter 2026 Financial Results - BioSpace
AtriCure revenue up 12.8% to USD 153.6M in Q2 2026 - Medical Buyer
AtriCure Inc (ATRC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AtriCure Inc (ATRC) Q2 2026 Earnings Call Highlights: Strong Rev - GuruFocus
AtriCure Inc (ATRC) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Profitability ... - Yahoo Finance
AtriCure 2Q Net $8.96M >ATRC - Moomoo
AtriCure (ATRC) Reports Strong Q2 2026 Results with Revenue Grow - GuruFocus
AtriCure Releases Q2 2026 Financial Results - AlphaStreet
AtriCure Q2 Swings to Adjusted Earnings, Revenue Rises - Moomoo
Transcript : AtriCure, Inc., Q2 2026 Earnings Call, Jul 23, 2026 - marketscreener.com
AtriCure (ATRC) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
AtriCure Q2 Earnings Call Highlights - TradingView
Is AtriCure Inc (ATRC) Undervalued After Q2 Earnings Beat? EPS $0.18 on Revenue of $153.6M -- GF Score 78/100 - GuruFocus
Earnings call transcript: AtriCure tops Q2 2026 estimates, shares fall after hours - Investing.com
AtriCure Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
AtriCure (ATRC) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
AtriCure surges 3% on earnings beat and raised guidance - Investing.com India
AtriCure surges 3% on earnings beat and raised guidance By Investing.com - Investing.com South Africa
AtriCure (NASDAQ:ATRC) Profitability Surge Drives After-Hours Rally Despite Inline Revenue - ChartMill
ATRICURE ($ATRC) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
Q2 2026 AtriCure Inc Earnings Call Transcript - GuruFocus
AtriCure set to report earnings as competitive threat looms - Investing.com UK
(ATRC) AtriCure Expects 2026 Adjusted EPS Range $0.24-$0.32, vs. FactSet Est of $0.12 - marketscreener.com
(ATRC) AtriCure Expects 2026 Revenue Range $602M-$610M, vs. FactSet Est of $604.6M - marketscreener.com
GUIDANCE: (ATRC) AtriCure Expects 2026 Adjusted EPS Range $0.24-$0.32, Vs. FactSet Est of $0.12 - Moomoo
AtriCure: Q2 Earnings Snapshot - The Daily Independent
Earnings Flash (ATRC) AtriCure, Inc. Reports Q2 Revenue $153.6M, vs. FactSet Est of $151.8M - marketscreener.com
Earnings Flash (ATRC) AtriCure, Inc. Posts Q2 Adjusted EPS $0.18 per Share, vs. FactSet Est of $0.00 - marketscreener.com
AtriCure reports Q2 2026 revenue $153.6M, net income $9.0M and adjusted EBITDA $27.3M - TradingView
BRIEF-AtriCure Q2 Adjusted EPS USD 0.18 Vs. IBES Estimate USD 0 - TradingView
AtriCure Outlook FY Revenue USD 602-610 Milli - Moomoo
AtriCure set to report earnings as competitive threat looms By Investing.com - Investing.com India
ATRC|AtriCure Inc|Price:37.390|Chg%:+0.020 - TradingKey
Citizens reiterates AtriCure stock rating on product growth outlook - Investing.com UK
Hybrid AF therapy offers new rhythm care as AtriCure stock trades down from last week - Traders Union
Citizens reiterates AtriCure stock rating on product growth outlook By Investing.com - Investing.com Canada
AtriCure stock consolidates above key averages amid strong trend signals and recent care milestone - Traders Union
AtriCure unveils AtriClip Mini as AtriCure stock trades up to 35.16 amid bullish momentum - Traders Union
AtriCure (ATRC) Proxy filing Summary - Quartr
AtriCure (ATRC) Declines 1.88%, Approaches Key Support at $33.2Momentum Breakout Ideas - dars.gov.et
0.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):